Tr.ang.ngsund, Sweden

Bengt Ang Sparf

This inventor holds 2 USPTO granted patents. Top assignees: Pharmacia Ab, Pharmacia Aktiebolag. Active years: 1995-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bengt Ang Sparf. Retrieved from https://idiyas.com/inventor/bengt-ang-sparf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bengt Ang Sparf: Innovator in Pharmaceutical Chemistry

Introduction

Bengt Ang Sparf is a notable inventor based in Tr.ang.ngsund, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 3,3-diphenylpropylamines. With a total of 2 patents to his name, Sparf's inventions have the potential to impact drug development and therapeutic applications.

Latest Patents

Sparf's latest patents focus on the preparation and use of 3,3-diphenylpropylamines. The first patent describes these compounds, which include various functional groups and their potential as pharmaceutical agents. The second patent further elaborates on the novel 3,3-diphenylpropylamines, emphasizing their use as anticholinergic agents and their applications in drug formulation. These patents highlight the versatility and therapeutic potential of these compounds in the pharmaceutical industry.

Career Highlights

Throughout his career, Sparf has worked with prominent companies in the pharmaceutical sector, including Pharmacia Aktiebolag and Pharmacia AB. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Sparf has collaborated with notable colleagues such as Pinchas Moses and Nils A Jonsson. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Bengt Ang Sparf's contributions to pharmaceutical chemistry through his patents on 3,3-diphenylpropylamines demonstrate his commitment to advancing drug development. His work continues to influence the field and holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…